Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether The general population may be useful for adults experiencing somatic symptom disorders.
What would participation involve?
Participants may complete study activities around The general population, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in China.
Who is it mainly for?
This study appears to be mainly for adults with somatic symptom disorders.
What should you check before joining?
Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: September 1, 2017
Recruitment status
Unknown
Enrollment listed in the registry
2,000
Sponsor
RenJi Hospital
Sponsor type
Hospital / academic medical center
Study type
Diagnostic Test
Intervention type
DIAGNOSTIC_TEST
Study phase
Not clearly listed
Locations
China
Age range
From 18 Years to 80 Years
Official registry ID
NCT03321409
Official title
The Validation of the Somatic Symptom Scale China (SSS-CN) for Assessing Somatic Symptom Burden and Its Utility in Patients With Suspected Coronary Artery Disease
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03321409. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
Status unknown
Shanghai
Registry details
Registry conditions (original wording)
Somatization Disorder
FAQ
Questions about this study
Who is behind this study?
The study sponsor is RenJi Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 80 years.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
